学習資料をアップロードして、すべてのドキュメントをダウンロードしてください。Unfit people also have the choice of venetoclax furthermore obinutuzumab (VO) as frontline therapy. This is predicated with a phase III demo that when compared VO with ClbO in aged/unfit sufferers.113 VO was superior regarding reaction